The effects of isolation extend far beyond children’s time in the hospital,” writes medical student Anna Tsioulias.

ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on ...

Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors cannot ...

As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and ...

Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...

Regulators at the FDA have reiterated concerns that Replimmune does not have adequate data to support an approval of its ...

Growing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence ...

A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the U.S.

One year after launching the CMS Health Tech Ecosystem, officials convened in D.C. to celebrate the Trump administration ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Half a year into taking ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Rarely has a new technology so squarely ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...